Aprogen Medicines Valuation

Is A007460 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A007460 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate A007460's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A007460's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A007460?

Key metric: As A007460 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A007460. This is calculated by dividing A007460's market cap by their current revenue.
What is A007460's PS Ratio?
PS Ratio	2.3x
Sales	₩147.85b
Market Cap	₩335.70b

A007460 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.9x
Enterprise Value/EBITDA	-12.3x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does A007460's PS Ratio compare to its peers?

The above table shows the PS ratio for A007460 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.2x
A114190 KANGWON ENERGY	1.2x	n/a	₩283.4b
A090710 Hyulim ROBOTLtd	1.9x	n/a	₩179.5b
A100840 SNT Energy	1.3x	28.8%	₩358.7b
A282880 COWINTECH	0.5x	11.1%	₩160.6b
A007460 Aprogen Medicines	2.3x	n/a	₩335.7b

Price-To-Sales vs Peers: A007460 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the peer average (1.2x).

Price to Sales Ratio vs Industry

How does A007460's PS Ratio compare vs other companies in the KR Machinery Industry?

7 Companies	Price / Sales	Estimated Growth	Market Cap
A013570 DY	0.09x	n/a	US$78.60m
A024880 Korea Parts & FastenersLtd	0.09x	7.1%	US$52.16m
A067170 Autech	0.06x	n/a	US$36.87m
A119650 KC Cottrell	0.09x	n/a	US$24.18m

7 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: A007460 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the KR Machinery industry average (0.9x).

Price to Sales Ratio vs Fair Ratio

What is A007460's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A007460 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2.3x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate A007460's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Hanwha

₩2.0t

Engages in the explosives, trading, and construction businesses.

A000880

₩27,900.00

-4.6%

10.5%

Hy-Lok

₩325.6b

Operates in the fluid and control system industry worldwide.

A013030

₩26,900.00

8.2%

-3.1%

Doosan Enerbility

₩13.5t

Operates as an energy company worldwide.

A034020

₩21,050.00

-6.0%

37.9%